Vanderbilt Hemostasis-Thrombosis Clinic — Nashville, Tennessee

Vanderbilt Hemostasis-Thrombosis Clinic is a clinical research site located in Nashville, Tennessee, United States 37232.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Vanderbilt Hemostasis-Thrombosis Clinic has participated in 2 clinical trials.

Therapeutic areas: Hemophilia B, Hemophilia A.

Sponsors: Ultragenyx Pharmaceutical Inc, Pfizer.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vanderbilt Hemostasis-Thrombosis Clinic?

Vanderbilt Hemostasis-Thrombosis Clinic has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vanderbilt Hemostasis-Thrombosis Clinic conducted?

Vanderbilt Hemostasis-Thrombosis Clinic has 2 clinical trials on record. Their work covers Hemophilia B, Hemophilia A.

Is Vanderbilt Hemostasis-Thrombosis Clinic accredited by Crixeo Health?

Vanderbilt Hemostasis-Thrombosis Clinic has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Vanderbilt Hemostasis-Thrombosis Clinic?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.